Exhibit 4.4 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,...Kaire Holdings Inc • August 27th, 2001 • In vitro & in vivo diagnostic substances • New York
RECITALSAgreement and Plan of Reorganization • December 23rd, 1997 • Interactive Medical Technologies LTD • In vitro & in vivo diagnostic substances • Delaware
ARTICLE IKaire Holdings Inc • August 27th, 2001 • In vitro & in vivo diagnostic substances • New York
Exhibit 10.40 SECOND ADDENDUM TO AGREEMENT AND PLAN OF MERGER ----------------------------------------------- This SECOND ADDENDUM TO AGREEMENT AND PLAN OF MERGER is made this December 6, 2000, by and among Kaire Holdings, Incorporated, a Delaware...Agreement and Plan of Merger • March 20th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances
EXHIBIT 4.4 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,...Kaire Holdings Inc • May 3rd, 2001 • In vitro & in vivo diagnostic substances • New York
CONSULTING AGREEMENT --------------------Consulting Agreement • July 18th, 1997 • Interactive Medical Technologies LTD • In vitro & in vivo diagnostic substances
ARTICLE IKaire Holdings Inc • May 3rd, 2001 • In vitro & in vivo diagnostic substances • New York
Exhibit 4.1 Advisory and Consulting Agreement Number of Shares and Options ----------------------------Consulting Agreement • October 15th, 1999 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
Exhibit 10.38 MODIFICATION AGREEMENT ---------------------- WHEREAS, as of October 26, 2000 and January 10, 2001, Kaire Holdings, Incorporated, a Delaware corporation (the "Company"), pursuant to Subscription Agreement dated October 26, 2000...Modification Agreement • March 20th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances
RECITALSExhibit 99 • June 7th, 2002 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
WITNESSETHConsulting Agreement • August 5th, 2003 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
ContractKaire Holdings Inc • September 8th, 2005 • In vitro & in vivo diagnostic substances • New York
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO KAIRE HOLDINGS INCORPORATED THAT SUCH REGISTRATION IS NOT REQUIRED.
SUBSCRIPTION AGREEMENTSubscription Agreement • September 8th, 2005 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of June 23, 2005, by and among Kaire Holdings, Inc., a Delaware corporation (the “Company”), and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subscribers”).
Exhibit 4.1 Advisory and Consulting Agreement Number of Shares and Options ---------------------------- 4.1(a) 1,000,000 4.1(b) 1,000,000 4.1(c) 300,000 4.1(d) 1,000,000 4.1(e) 300,000 Other Consultants 1,350,000 Exhibit 4.1(a) CONSULTING AGREEMENT...Consulting Agreement • February 11th, 2000 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
WITNESSETHConsulting Agreement • February 18th, 2003 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.42 ------------- SUBSCRIPTION AGREEMENT ---------------------- Dear Subscriber: You (the "Subscriber") hereby agree to purchase, and Kaire Holdings Incorporated, a Delaware corporation (the "Company") hereby agrees to issue and to sell to...Subscription Agreement • May 3rd, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances
WITNESSETHConsulting Agreement • March 27th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
Exhibit 4.1 Advisory and Consulting Agreement Number of Shares and Options ---------------------------- 4.1(a) as amended 11,150,000Consulting Agreement • May 25th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
ARTICLE 1. THE MERGERAgreement and Plan of Merger • June 22nd, 2000 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • Delaware
Exhibit 4.2 This Agreement (the "Agreement") is dated February 17, 2003 and is entered into by and between KAIRE HOLDINGS, INC. (hereinafter "KAHI" or "CLIENT") and George Lefevre and Scott Absher (otherwise known as NEOTACTIX, INC.) (hereinafter...Agreement • February 18th, 2003 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
Exhibit 10.32 SUBSCRIPTION AGREEMENT ---------------------- Dear Subscriber: You (the "Subscriber") hereby agree to purchase, and Kaire Holdings Incorporated, a Delaware corporation (the "Company") hereby agrees to issue and to sell to the Subscriber,...Subscription Agreement • December 13th, 2000 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • September 6th, 2016 • International Packaging & Logistics Group Inc. • Wholesale-machinery, equipment & supplies
This Consulting Services Agreement (this “Agreement”) is dated August 31, 2016, and is entered into in Xinglong Industry Park, Yanzhou City, Jining, , Shandong, China between YibaoConfucian Co., Ltd, with a registered address at Rm. 19C, Lockhart Ctr., 301-307 Lockhart Rd., Wan Chai, Hong Kong (“Party A”), and Shangdong Confucian Biologics Co. Ltd., with a registered address at Xinglong Industry Park, Yanzhou City, Jining, , Shandong, China (“Party B”),. Party A and Party B are referred to collectively in this Agreement as the “Parties.”
Exhibit 4.1 This Agreement (the "Agreement") is dated February 17, 2003 and is entered into by and between KAIRE HOLDINGS, INC. (hereinafter "KAHI" or "CLIENT") and George Lefevre and Scott Absher (otherwise known as NEOTACTIX, INC.) (hereinafter...This Agreement • February 18th, 2003 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
ARTICLE IKaire Holdings Inc • December 13th, 2000 • In vitro & in vivo diagnostic substances • New York
CONVERTIBLE NOTEKaire Holdings Inc • January 23rd, 2006 • In vitro & in vivo diagnostic substances • New York
This Note has been entered into pursuant to the terms of a subscription agreement between the Borrower and the Holder, dated of even date herewith (the “Subscription Agreement”), and shall be governed by the terms of such Subscription Agreement. Unless otherwise separately defined herein, all capitalized terms used in this Note shall have the same meaning as is set forth in the Subscription Agreement. The following terms shall apply to this Note:
SECURED CONVERTIBLE NOTEKaire Holdings Inc • September 8th, 2005 • In vitro & in vivo diagnostic substances • New York
This Note has been entered into pursuant to the terms of a subscription agreement between the Borrower and the Holder, dated of even date herewith (the “Subscription Agreement”), and shall be governed by the terms of such Subscription Agreement. Unless otherwise separately defined herein, all capitalized terms used in this Note shall have the same meaning as is set forth in the Subscription Agreement. The following terms shall apply to this Note:
EQUITY PLEDGE AGREEMENTEquity Pledge Agreement • September 6th, 2016 • International Packaging & Logistics Group Inc. • Wholesale-machinery, equipment & supplies
This Equity Pledge Agreement (hereinafter this “Agreement”) is dated August 31, 2016, and entered into in Xinglong Industry Park, Yanzhou City, Jining, , Shandong, China by YibaoConfucian Co., Ltd, with a registered address Rm. 19C, Lockhart Ctr., 301-307 Lockhart Rd., Wan Chai, Hong Kong (“Pledgee”), and each of the shareholders of Party B listed on the signature pages hereto (collectively, the “Pledgors”), and Shangdong Confucian Biologics Co. Ltd., with a registered address at Xinglong Industry Park, Yanzhou City, Jining, , Shandong, China (“Party B” or “Company”),
EMPLOYMENT AGREEMENTEmployment Agreement • December 8th, 2016 • International Packaging & Logistics Group Inc. • Wholesale-machinery, equipment & supplies • Nevada
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of December 1, 2016 by and between International Packaging and Logistics Group, Inc., Inc., a Nevada Company (the “Company”), and Xiuhua Song (the “Employee”).
Exhibit 10.41 ------------- SUBSCRIPTION AGREEMENT ---------------------- Dear Subscriber: You (the "Subscriber") hereby agree to purchase, and Kaire Holdings Incorporated, a Delaware corporation (the "Company") hereby agrees to issue and to sell to...Subscription Agreement • August 27th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
EXHIBIT 2.2 FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER This First Amendment to Agreement and Plan of Merger (the "First Amendment") is entered into and effective as of May __, 2000 by and among Kaire Holdings, Inc., a Delaware corporation, Kaire...Agreement and Plan of Merger • June 22nd, 2000 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances
1. Vote on Merger and Related Matters. The Constituent Corporations ------------------------------------- shall each, as soon as practicable, but prior to closing, and in no event later than 10 days after the execution and delivery hereof, (i) cause a...Acquisition Agreement and Plan of Merger • March 20th, 2003 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • Nevada
WITNESSETHAcquisition Agreement • July 21st, 1997 • Interactive Medical Technologies LTD • In vitro & in vivo diagnostic substances • California
ContractKaire Holdings Inc • June 21st, 2004 • In vitro & in vivo diagnostic substances • New York
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO KAIRE HOLDINGS INCORPORATED THAT SUCH REGISTRATION IS NOT REQUIRED.
OPTION AGREEMENTOption Agreement • September 6th, 2016 • International Packaging & Logistics Group Inc. • Wholesale-machinery, equipment & supplies
This Option Agreement (this “Agreement”) is entered into, as of August 31, 2016, in Xinglong Industry Park,Yanzhou City, Jining, Shandong, China by YibaoConfucian Co., Ltd, with a registered address at Rm. 19C, Lockhart Ctr., 301-307 Lockhart Rd., Wan Chai, Hong Kong (“Party A”), Shangdong Confucian Biologics Co. Ltd., with a registered address at Xinglong Industry Park,Yanzhou City, Jining, Shandong, China (“Party B”), and each of the shareholders of Party B listed on the signature pages hereto (collectively, the “Party C”), Party A, Party B and Party C are referred to collectively in this Agreement as the “Parties.”
STOCK PURCHASE AGREEMENT BETWEEN XIUHUA SONGSHANDONG TBD CHINA COMPANY. And INTERNATIONAL PACKAGING AND LOGISTICS GROUP, INC. STANDARD RESOURCES LTD. STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 11th, 2016 • International Packaging & Logistics Group Inc. • Wholesale-machinery, equipment & supplies • Nevada
THIS STOCK PURCHASE AGREEMENT, dated as of May 15, 2016, by and between Xiuhua Song (the “Buyer”), and TBD China Company (Shangdong Kangfusen Biotech Co. Ltd., a China Company or Shandong Yibao Biologics Co. LTD) and International Packaging and Logistics Group, Inc. (the “Seller”)(the “Company”) and Standard Resources Ltd.. As used herein, the term “Parties” shall be used to refer to the Buyer and the Seller, jointly.
